Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports

Indonesia Berita Berita

Merck nears $1.3 billion cash deal for eye-drug company EyeBio, WSJ reports
Indonesia Berita Terbaru,Indonesia Berita utama

Explore stories from Atlantic Canada.

Seniors displaced after Yarmouth fire | SaltWire #fire #yarmouth #seniors #news -Merck & Co is nearing a $1.3 billion cash deal to buy ophthalmology biotechnology company Eyebiotech in an agreement that could see an additional $1.7 billion in milestone payments, the Wall Street Journal reported on Tuesday.

Eyebiotech is a clinical stage opthalmology company, with operations in the U.S. and the UK, that seeks to treat patients with sight-threatening diseases.

 

Indonesia Berita Terbaru, Indonesia Berita utama



Render Time: 2025-01-10 22:09:48